CHUGAI PHARMACEUTICAL CO.,LTD.｜INNOVATION BEYOND IMAGINATION

Oct 30, 2017 "CEO Meeting" was held for the media.
Apr 3, 2017 Beware of Solicitations, "Phishing" e-mails, and SNS that Fraudulently Use the Name of Chugai Pharmaceutical

News Releases
What's New

Sep 21: For Media ＆ IRCSR
Contribution of Para-transit Vehicles to Welfare Services
Sep 20: For Media ＆ IRCorporateProduct
Announcement Regarding the Order to Dismiss in a Lawsuit against Chugai in the U.S.
Sep 14: For Media ＆ IRCorporate
Chugai Selected for the Fourth Time for Dow Jones Sustainability Asia Pacific Index
Sep 14: For Media ＆ IRCorporate
Organizational and Personnel Changes
Aug 30: For Media ＆ IRR&D
Results of Global Phase III Study with Chugai's HEMLIBRA^® for Hemophilia A without Inhibitors Published in the New England Journal of Medicine

More

Aug 03: Established ESG information site “ESG at Chugai”
Jul 30: Webcast of Investor Conference on FY2018 2Q Financial Results
Jul 27: Posted Corporate Governance Reports
Jul 27: Investor Conference on FY2018 2Q Financial Results
Jul 26: Financial Results for Second Quarter of Fiscal Year 2018 (January - June, 2018)

Share Price

TSE Code 4519

Share Graph

Video Introduction of CHUGAI

Videos & Advertisements

Back to top

Chugai Pharmaceutical Co., Ltd. takes great care over the information presented on this website, but it does not guarantee its accuracy, completeness, usefulness, etc. Furthermore, Chugai Pharmaceutical Co., Ltd. will not be responsible for any damages resulting from the use of this website or the information presented on this website. For further details, please read the following "Terms and Conditions of Website Use."

Share Price

Message from the CEO

R&D

Development
Pipeline

CSR

Recruit

Video Introduction of CHUGAI

Share Price

Message from the CEO

R&D

DevelopmentPipeline

CSR

Recruit

Video Introduction of CHUGAI

Development
Pipeline